Number and activation of circulating polymorphonuclear leukocytes and platelets are associated with neonatal respiratory distress syndrome severity

Pediatrics

Volumn 99, Issue 5, 1997, Pages 672-680

  Brus, Frank ^a   Van Oeveren, Willem ^b   Okken, Albert ^a   Bambang Oetomo, Sidarto ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

elastase; neonatal respiratory distress syndrome severity; platelets; polymorphonuclear leukocytes; thromboxane

Indexed keywords

ALPHA 1 ANTITRYPSIN; ELASTASE; THROMBOXANE B2;

APGAR SCORE; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; INFANT; LEUKOCYTE ACTIVATION; LEUKOCYTE COUNT; LUNG ALVEOLUS OXYGEN TENSION; MALE; NEWBORN; NEWBORN INTENSIVE CARE; PERINATAL ASPHYXIA; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT;

EID: 0030969414     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.99.5.672     Document Type: Article

References (47)

1. Ogden BE, Murphy SA, Saunders GC, Pathak D, Johnson JD. Neonatal lung neutrophils and elastase/proteinase inhibitor imbalance. Am Rev Respir Dis. 1984;130:817-821
2. Merritt TA, Cochrane CG, Holcomb K, et al. Elastase and α-1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. J Clin Invest. 1983;72:656-666
3. Groneck P, Götze-Speer B, Oppermann M, Eiffert H, Speer CP. Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm neonates. Pediatrics. 1994;93:712-718
4. Groneck P, Reuss D, Götze-Speer B, Speer CP. Effects of dexamethasone on chemotactic activity and inflammatory mediators in tracheobronchial aspirates of preterm infants at risk for chronic lung disease. J Pediatr. 1993;122:938-944
5. Sibille Y, Reynolds HY. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am Rev Respir Dis. 1990;141:471-501
6. Speer CP, Ruess D, Harms K, Herting E, Gefeller O. Neutrophil elastase and acute pulmonary damage in neonates with severe respiratory distress syndrome. Pediatrics. 1993;91:794-799
7. Murch SH, MacDonald TT, Wood CBS, Costeloe KL. Tumor necrosis factor in the bronchoalveolar secretions of infants with the respiratory distress syndrome and the effect of dexamethasone treatment. Thorax. 1992;47:44-47
8. Stenmark KR, Eyzaguirre M, Westcott JY, Henson PM, Murphy RC. Potential role of eicosanoids and PAF in the pathophysiology of bronchopulmonary dysplasia. Am Rev Respir Dis. 1987;136:770-772
9. Stephens KE, Ishizaka A, Larrick JW, Raffin TA. Tumor necrosis factor causes increased pulmonary permeability and edema. Comparison to septic acute lung injury. Am Rev Respir Dis. 1988;137:1364-1370
10. Stimler NP, Hugli TE, Bloor CM. Pulmonary injury induced by C3a and C5a anaphylatoxins. Am J Pathol. 1980;100:327-348
11. Kunkel SL, Standiford T, Kasahara K, Strieter RM. Interleukin-8: the major neutrophil chemotactic factor in the lung. Exp Lung Res. 1991;17:17-23
12. Brus F, van Oeveren W, Bambang Oetomo S, Okken A. Activation of circulating polymorphonuclear leukocytes in preterm infants with severe idiopathic respiratory distress syndrome. Pediatr Res. 1996;39: 456-463
13. Kohelet D, Perlman M, Hanna G, Ballin A. Reduced platelet counts in neonatal respiratory distress syndrome. Biol Neonate. 1990;57:334-342
14. Brus F, van Oeveren W, Okken A, Bambang Oetomo S. Activation of the plasma clotting, fibrinolytic, and kinin-kallikrein system in preterm infants with severe idiopathic respiratory distress syndrome. Pediatr Res. 1994;36:647-653
15. Mehta P, Rohitkumar V, Neumann L, Karpatkin M. Thrombocytopenia in the high risk infant. J Pediatr. 1980;97:791-794
16. Schmidt B, Vegh P, Weitz J, Johnston M, Caco C, Roberts R. Thrombin/ antithrombin III complex formation in the neonatal respiratory distress syndrome. Am Rev Respir Dis. 1992;145:767-770
17. Lefer AM. Role of the prostaglandin-thromboxane system in vascular homeostasis during shock. Circ Shock. 1979;6:297-303
18. O'Flaherty JT, Showell HS, Becker EL, Ward PA. Arachidonic acid aggregates neutrophils. Inflammation. 1979;3:431-435
19. Staub NC. Pulmonary edema. Physiol Rev. 1974;54:679-811
20. Hubbard RC, Brantly ML, Crystal RG. Proteases. In: Crystal RG, West JB, Bames PJ, Cherniak NS, Weibel ER, eds. The Lung. New York, NY: Raven Press, Ltd; 1991:1763-1773
21. Viinika L, Ylikorkala O. Measurement of thromboxane B2 in human plasma or serum by radioimmunoassay. Prostaglandins. 1980;20:759-766
22. Giedion A, Haefliger H, Dangel P. Acute pulmonary x-ray changes in hyaline membrane disease treated with artificial ventilation and positive end expiratory pressure. Pediatr Radiol. 1973;1:145-152
23. Bancalari E, Abdenour GE, Feller R, Gannon J. Bronchopulmonary dysplasia: clinical presentation. J Pediatr. 1979;95:819-823
24. Levene MI, Williams JL, Fawer CL. Ultrasound of the infant brain. In: Clinics in Developmental Medicine. Oxford, United Kingdom: Blackwell Scientific Publications Ltd; 1985;92
25. Gortner L. A multicenter randomized controlled clinical trial of bovine surfactant for prevention of respiratory distress syndrome. Lung. 1990; 168(suppl):864-869
26. Gortner L, Bartmann P, Pohland F, et al. Early treatment of respiratory distress syndrome with bovine surfactant in very preterm infants: a multicenter controlled clinical trial. Pediatr Pulmonol. 1992;14:112-119
27. Gu YJ, Obster R, de Haan J, Gallandat Huet RCG, van Oeveren W. Biocompatibility of leukocyte removal filters during bedside leukocyte filtration of red cell concentrates. Transfus Sci. 1992;13:467-472
28. Redmond CR, Loe WA, Bartlett RH, Arensman RM. Extracorporeal membrane oxygenation. In: Goldsmith JP, Karotkin EH, Barker S, eds. Assisted Ventilation of the Neonate. Philadelphia, PA: WB Saunders; 1988:200-212
29. O'Rourke PP, Crone RK, Vacanti JP, et al. Extracorporeal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hypertension of the newborn: a prospective randomized study. Pediatrics. 1989;84:957-963
30. Notter RH, Egan EA, Kwong MS, Holm BA, Shapiro DL. Lung surfactant replacement in premature lambs with extracted lipid from bovine lung lavage: effects of dose, dispersion technique and gestational age. Pediatr Res. 1985;19:569-577
31. Heffner JE, Sahn SA, Repine JE. The role of platelets in the adult respiratory distress syndrome Culprits or bystanders? Am Rev Respir Dis. 1987;135:482-492
32. Roall JA, Levin DL. Adult respiratory distress syndrome in pediatric patients: I. Clinical aspects, pathophysiology, and mechanisms of lung injury. J Pediatr. 1987;112:169-180
33. Sarnaik AP, Lieh-Lai M. Adult respiratory distress syndrome in children. Pediatr Clin North Am. 1994;41:337-364
34. Malik AB, Horgan MJ. Mechanisms of thrombin-induced lung vascular injury and edema. Am Rev Respir Dis. 1987;136:467-470
35. Haynes JB, Hyers TM, Giclas PC, Franks JJ, Petty TL. Elevated fibrin degradation products in ARDS. Am Rev Respir Dis. 1988;122:841-847
36. Stewart JM. The kinin system in inflammation. Agents Actions Suppl. 1993;42:145-157
37. Bektas S, Götze B, Speer CP. Decreased adherence, chemotaxis and phagocytic activities of neutrophils from preterm infants. Acta Paediatr Scand. 1990;79:1031-1038
38. Plötz FB, van Oeveren W, Bartlett RH, Wildevuur ChRH. Blood activation during neonatal extracorporeal life support (ECLS). J Thorac Cardiovasc Surg. 1993;105:823-832
39. Renesto P, Chignard M. Enhancement of cathepsin G-induced platelet activation by leukocyte elastase: consequence for neutrophil-mediated platelet activation. Blood. 1993;82:139-144
40. Stuart MJ, Dusse J, Clark DA, Walenga RW. Differences in thromboxane production between neonatal and adult platelets in response to arachidonic acid and epinephrine. Pediatr Res. 1984;18:823-826
41. Bui KC, Hammerman C, Hirschl RB, et al. Plasma prostanoids in neonates with pulmonary hypertension treated with conventional therapy and with extracorporeal membrane oxygenation. J Thorac Cardiovasc Surg. 1991;101:973-983
42. Le Guennec JC, Lauziere M, Black R, Sirois P. Effects of indomethacin on prostaglandin E2 and thromboxane B2 contents of tracheal lavage fluids in premature infants. Inflammation. 1991;15:55-59
43. Gerdes JS, Harris MC, Polin RA. Effects of dexamethasone and indomethacin on elastase, a1-proteinase inhibitor, and fibronectin in bronchoalveolar lavage fluid from neonates. J Pediatr. 1988;113:727-731
44. Koenig JM, Christensen RD. Incidence, neutrophil kinetics, and natural history of neonatal neutropenia associated with maternal hypertension. N Engl J Med. 1991;321:557-562
45. Brazy JE, Grimm JK, Little VA. Neonatal manifestations of severe maternal hypertension occurring before the thirty-sixth week of pregnancy. J Pediatr. 1982;100:265-271
46. Jansen NJG, van Oeveren W, van Vliet M, Stoutenbeek CP, Eysman L, Wildevuur ChRH. The role of different types of corticosteroids in the inflammatory mediators in cardiopulmonary bypass. Eur J Cardiothorac Surg. 1991;5:211-217
47. Katz J, Rodriguez E, Mandani G, Branson HE. Normal coagulation findings, thrombocytopenia and peripheral hemoconcentration in neonatal polycytaemia. J Pediatr. 1982;101:99-102